Evidence map›Paper›PMID 40711454›Full record

ArticleBiotechnology journal2025

Metabolic Engineering of Komagataella phaffii and Process Optimization for Biosynthesis of 1,2,4-Butanetriol From Xylose.

Débora Trichez, Thályta Pacheco, Clara Vida G C Carneiro, Jessica C Bergmann, João Ricardo M de Almeida

Abstract read
In one paragraph

Article in Biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Débora TrichezMicrobial Genetics and Biotechnology Laboratory, EMBRAPA Agroenergy, Brasília, Brazil.
Thályta PachecoMicrobial Genetics and Biotechnology Laboratory, EMBRAPA Agroenergy, Brasília, Brazil.
Clara Vida G C CarneiroMicrobial Genetics and Biotechnology Laboratory, EMBRAPA Agroenergy, Brasília, Brazil.
Jessica C BergmannMicrobial Genetics and Biotechnology Laboratory, EMBRAPA Agroenergy, Brasília, Brazil.
João Ricardo M de AlmeidaMicrobial Genetics and Biotechnology Laboratory, EMBRAPA Agroenergy, Brasília, Brazil.ORCID https://orcid.org/0000-0002-2902-5805

Funding

CAPES, CNPq, INCT Industrial Biotechnology, and FAP-DF
6 · The paper itself

Abstract

1,2,4-butanetriol (BTO) is a four-carbon polyol used as a precursor for synthesizing pharmaceuticals, polymers, and energetic plasticizers. The present study demonstrates the microbial production of BTO from xylose by engineered Komagataella phaffii yeast strains for the first time. The pathway was established through the overexpression of the enzymes xylose dehydrogenase (XylB), xylonate dehydratase (XylD), and 2-ketoacid decarboxylase (KDC). Two xylonate dehydratase genes, xylD-CC from Caulobacter crescentus and xylD-HL from Halomonas lutea, were evaluated in the constructions, both enabling BTO production. Furthermore, to improve BTO production, a central composite design analysis (CCD) was employed, identifying the best cultivation conditions to improve yeast performance. Under these optimized conditions, the engineered K. phaffii strain produced 1.3 g/L of BTO, achieving a 147% increase compared to the initial setup. Although further genetic engineering efforts are required to enhance BTO production, this study provides insights into potential improvement targets and highlights K. phaffii as a promising platform for the bio-based synthesis of chemical compounds like BTO.

Indexed as

ButanolsMetabolic EngineeringSaccharomycetalesXyloseBacterial ProteinsCaulobacter crescentusHalomonasBacterial ProteinsButanolsXylose1,2,4‐butanetriolbioprocess engineeringKomagataella phaffiixylose

Identifiers

PMID40711454
PMCPMC12292740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.